Nobuaki Watanabe
Nishinomiya-hama, 6620971, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Prospective cohort study of cancer incidence and related factors among patients with type 2 diabetes in Japan.
Journal: Diabetes research and clinical practice
Published: June 27, 2026
Continuous glucose monitoring-derived time in range is associated with changes in cognitive function test scores in Japanese patients with type 2 diabetes mellitus.
Journal: Diabetes, obesity & metabolism
Published: March 27, 2025
A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins.
Journal: European journal of drug metabolism and pharmacokinetics
Published: July 04, 2023
Unveiling the intra-tumor fate of trastuzumab deruxtecan in a xenograft model to support its mechanism of action.
Journal: Drug metabolism and pharmacokinetics
Published: June 20, 2023
Transition of average drug-to-antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography-tandem mass spectrometry.
Journal: Biopharmaceutics & drug disposition
Published: April 03, 2023
Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective NaV1.7 Inhibitor DS-1971a, a Mixed Substrate of Cytochrome P450 and Aldehyde Oxidase, Using Chimeric Mice With Humanized Liver.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 23, 2022
Motivation for Treatment Correlating Most Strongly with an Increase in Satisfaction with Type 2 Diabetes Treatment.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 01, 2022
Species differences between rats and primates (humans and monkeys) in complex cleavage pathways of DS-8500a characterized by 14C-ADME studies in humans and monkeys after administration of two radiolabeled compounds and in vitro studies.
Journal: Drug metabolism and pharmacokinetics
Published: September 16, 2021
CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective NaV1.7 Inhibitor DS-1971a, a Mixed Cytochrome P450 and Aldehyde Oxidase Substrate.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: September 03, 2021
Renadirsen, a Novel 2'OMeRNA/ENA® Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo.
Journal: Current issues in molecular biology
Published: August 02, 2021
Evaluation of species differences in the metabolism of the selective NaV1.7 inhibitor DS-1971a, a mixed substrate of cytochrome P450 and aldehyde oxidase.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: July 31, 2021
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Journal: Advances in therapy
Published: December 17, 2020
Last Updated: 09/26/2026